Stephens started coverage on shares of National Health Investors Inc. (NYSE:NHI) in a report released on Wednesday. The brokerage issued an overweight rating and a $84.00 price target on the real estate investment trust’s stock.

Other research analysts have also recently issued reports about the stock. Zacks Investment Research raised shares of National Health Investors from a hold rating to a buy rating and set a $86.00 target price for the company in a report on Wednesday, July 27th. Cantor Fitzgerald initiated coverage on shares of National Health Investors in a report on Thursday, June 23rd. They issued a hold rating and a $70.00 target price for the company. JMP Securities reaffirmed a hold rating on shares of National Health Investors in a report on Saturday, June 4th. Wells Fargo & Co. reaffirmed a hold rating on shares of National Health Investors in a report on Sunday, September 4th. Finally, Mizuho lifted their target price on shares of National Health Investors from $66.00 to $77.00 and gave the stock a neutral rating in a report on Monday, August 8th. Six analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. National Health Investors presently has a consensus rating of Hold and a consensus target price of $74.14.

National Health Investors (NYSE:NHI) opened at 78.65 on Wednesday. National Health Investors has a 12-month low of $54.51 and a 12-month high of $82.53. The company has a 50-day moving average of $79.44 and a 200 day moving average of $72.38. The company has a market capitalization of $3.08 billion, a P/E ratio of 18.14 and a beta of 0.65.

National Health Investors (NYSE:NHI) last issued its earnings results on Friday, August 5th. The real estate investment trust reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.21 by $0.01. The business earned $61.20 million during the quarter, compared to analysts’ expectations of $58.08 million. National Health Investors had a net margin of 69.69% and a return on equity of 14.68%. The business’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period in the previous year, the company earned $1.17 earnings per share. Equities research analysts forecast that National Health Investors will post $4.88 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Thursday, November 10th. Investors of record on Friday, September 30th will be given a dividend of $0.90 per share. The ex-dividend date is Wednesday, September 28th. This represents a $3.60 annualized dividend and a yield of 4.58%. National Health Investors’s dividend payout ratio (DPR) is 82.95%.

In related news, insider Kristin Sallee Gaines sold 8,652 shares of the business’s stock in a transaction that occurred on Wednesday, June 29th. The shares were sold at an average price of $73.98, for a total transaction of $640,074.96. Following the completion of the sale, the insider now directly owns 53,089 shares in the company, valued at $3,927,524.22. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Robert A. Mccabe, Jr. sold 800 shares of the business’s stock in a transaction that occurred on Tuesday, August 30th. The shares were sold at an average price of $80.29, for a total transaction of $64,232.00. Following the sale, the director now owns 10,021 shares of the company’s stock, valued at $804,586.09. The disclosure for this sale can be found here. Corporate insiders own 5.74% of the company’s stock.

Hedge funds have recently made changes to their positions in the stock. FMR LLC raised its stake in shares of National Health Investors by 35.0% in the second quarter. FMR LLC now owns 1,660,500 shares of the real estate investment trust’s stock valued at $124,687,000 after buying an additional 430,500 shares during the period. Vanguard Group Inc. raised its stake in shares of National Health Investors by 7.4% in the second quarter. Vanguard Group Inc. now owns 5,704,577 shares of the real estate investment trust’s stock valued at $428,356,000 after buying an additional 392,652 shares during the period. Norges Bank acquired a new stake in shares of National Health Investors during the fourth quarter valued at about $21,135,000. Mesirow Financial Investment Management Equity Management acquired a new stake in shares of National Health Investors during the second quarter valued at about $20,966,000. Finally, Emerald Acquisition Ltd. acquired a new stake in shares of National Health Investors during the second quarter valued at about $9,830,000. Institutional investors own 68.14% of the company’s stock.

About National Health Investors

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

5 Day Chart for NYSE:NHI

Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.